If severe combined immunodeficient (SCID) mice bearing human breast cancer xenograft was treated with 3-O-p-coumaroyltormentic acid, we could measure the concentration in plasma and tissues using LC mass, tumor size, and c-Myc stability. This evidence concerns the gene MYC and breast cancer.